Depreciation, Depletion and Amortization in USD of NKGen Biotech, Inc. from 2022 to 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
NKGen Biotech, Inc. quarterly and annual Depreciation, Depletion and Amortization history and change rate from 2022 to 2024.
  • NKGen Biotech, Inc. Depreciation, Depletion and Amortization for the quarter ending 31 Mar 2024 was $295,000, a 3% decline year-over-year.
  • NKGen Biotech, Inc. annual Depreciation, Depletion and Amortization for 2024 was $1,181,000, a 1.8% decline from 2023.
  • NKGen Biotech, Inc. annual Depreciation, Depletion and Amortization for 2023 was $1,203,000, a 0.58% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Change (%)

NKGen Biotech, Inc. Quarterly Depreciation, Depletion and Amortization (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $295,000 -$9,000 -3% 01 Jan 2024 31 Mar 2024 10-Q 20 May 2024 2024 Q1
Q1 2023 $304,000 01 Jan 2023 31 Mar 2023 10-Q 20 May 2024 2024 Q1

NKGen Biotech, Inc. Annual Depreciation, Depletion and Amortization (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,181,000 -$22,000 -1.8% 01 Jan 2024 31 Dec 2024 10-K 08 Oct 2025 2024 FY
2023 $1,203,000 -$7,000 -0.58% 01 Jan 2023 31 Dec 2023 10-K 08 Oct 2025 2024 FY
2022 $1,210,000 01 Jan 2022 31 Dec 2022 10-K 16 Apr 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.